432 related articles for article (PubMed ID: 12624111)
41. The accessibility of histone H3 tails in chromatin modulates their acetylation by P300/CBP-associated factor.
Herrera JE; Schiltz RL; Bustin M
J Biol Chem; 2000 Apr; 275(17):12994-9. PubMed ID: 10777601
[TBL] [Abstract][Full Text] [Related]
42. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
Li M; Damania B; Alvarez X; Ogryzko V; Ozato K; Jung JU
Mol Cell Biol; 2000 Nov; 20(21):8254-63. PubMed ID: 11027294
[TBL] [Abstract][Full Text] [Related]
44. Structure and ligand of a histone acetyltransferase bromodomain.
Dhalluin C; Carlson JE; Zeng L; He C; Aggarwal AK; Zhou MM
Nature; 1999 Jun; 399(6735):491-6. PubMed ID: 10365964
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
46. Acetylation of general transcription factors by histone acetyltransferases.
Imhof A; Yang XJ; Ogryzko VV; Nakatani Y; Wolffe AP; Ge H
Curr Biol; 1997 Sep; 7(9):689-92. PubMed ID: 9285713
[TBL] [Abstract][Full Text] [Related]
47. Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT.
Liu Y; Yang EJ; Shi C; Mou PK; Zhang B; Wu C; Lyu J; Shim JS
Int J Biol Sci; 2020; 16(11):1774-1784. PubMed ID: 32398948
[TBL] [Abstract][Full Text] [Related]
48. Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.
Li Q; Su A; Chen J; Lefebvre YA; Haché RJ
Mol Endocrinol; 2002 Dec; 16(12):2819-27. PubMed ID: 12456802
[TBL] [Abstract][Full Text] [Related]
49. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
50. Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.
Park S; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5335-E5342. PubMed ID: 28630323
[TBL] [Abstract][Full Text] [Related]
51. Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.
Konesky KL; Nyborg JK; Laybourn PJ
J Virol; 2006 Nov; 80(21):10542-53. PubMed ID: 16943293
[TBL] [Abstract][Full Text] [Related]
52. p300-mediated acetylation of human transcriptional coactivator PC4 is inhibited by phosphorylation.
Kumar BR; Swaminathan V; Banerjee S; Kundu TK
J Biol Chem; 2001 May; 276(20):16804-9. PubMed ID: 11279157
[TBL] [Abstract][Full Text] [Related]
53. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo.
Li Q; Herrler M; Landsberger N; Kaludov N; Ogryzko VV; Nakatani Y; Wolffe AP
EMBO J; 1998 Nov; 17(21):6300-15. PubMed ID: 9799238
[TBL] [Abstract][Full Text] [Related]
54. Acetyltransferase machinery conserved in p300/CBP-family proteins.
Yuan LW; Giordano A
Oncogene; 2002 Mar; 21(14):2253-60. PubMed ID: 11948408
[TBL] [Abstract][Full Text] [Related]
55. Acetylation of the BETA2 transcription factor by p300-associated factor is important in insulin gene expression.
Qiu Y; Guo M; Huang S; Stein R
J Biol Chem; 2004 Mar; 279(11):9796-802. PubMed ID: 14701848
[TBL] [Abstract][Full Text] [Related]
56. Kinetic mechanism of human histone acetyltransferase P/CAF.
Tanner KG; Langer MR; Denu JM
Biochemistry; 2000 Oct; 39(39):11961-9. PubMed ID: 11009610
[TBL] [Abstract][Full Text] [Related]
57. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
58. Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase.
Costi R; Di Santo R; Artico M; Miele G; Valentini P; Novellino E; Cereseto A
J Med Chem; 2007 Apr; 50(8):1973-7. PubMed ID: 17348637
[TBL] [Abstract][Full Text] [Related]
59. CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.
Kim JH; Cho EJ; Kim ST; Youn HD
Nat Struct Mol Biol; 2005 May; 12(5):423-8. PubMed ID: 15834423
[TBL] [Abstract][Full Text] [Related]
60. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
